| A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia |
Ongoing |
Tabuvan |
4 |
T-VAHST |
Prince Sultan Military Medical City (Riyadh) |
| Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury |
Ongoing |
N/A |
4 |
RC11/056 |
King Abdulaziz Medical City NG (Riyadh) |
| A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock |
Ongoing |
HYDROCORTISONE |
4 |
GI-CCT3722 |
King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh) |
| LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes |
Ongoing |
RANIBIZUMAB |
4 |
RFB002A240 |
king khaled eye specialist hospital (riyadh) |
| Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies |
Completed |
N/A |
4 |
ALX-MCD-502 |
King Fahad Medical City (Riyadh) |
| The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial |
Ongoing |
Caffeine |
4 |
E-15-1484 |
King Khalid University Hospital (Riyadh) |
| Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children. |
Ongoing |
HEPARIN |
4 |
RC12/145 |
King Abdulaziz Medical City NG (Riyadh) |
| The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis |
Ongoing |
Fingolimod (Glienya) |
4 |
FTY720D2404 |
King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh) |
| Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream |
Ongoing |
Meropenem / Piperacillin-Tazocin |
4 |
MED0313 |
King Fahad Specialist Hospital (Dammam) |
| Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE |
Completed |
Adalimumab |
4 |
10241 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
